Original Articles Open Access
Copyright ©The Author(s) 1998. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Aug 15, 1998; 4(4): 311-313
Published online Aug 15, 1998. doi: 10.3748/wjg.v4.i4.311
Effect of cytokines on liver necrosis
Yan-Yan Yu, Chong-Wen Si, Xiu-Lin Tian, Department of Infectious Diseases, The First Teaching Hospital, Beijing Medical University, Beijing 100034, China
Qun He, Hai-Peng Xue, Department of Pathology, The First Teaching Hospital, Beijing Medical University, Beijing 100034, China
Yan-Yan Yu, female, born on 1962-12-14 in Lanzhou City, Gansu Province, China, graduated from Beijing Medical University as a Ph.D. in 1994, now associate professor of infectious diseases majoring infectious diseases, having two papers published.
Author contributions: All authors contributed equally to the work.
Correspondence to: Dr. Yan-Yan Yu, Department of Infectious Diseases, The First Teaching Hospital, Beijing Medical University, Beijing 100034, China
Telephone: +86-10-66171122 ext 2362 Fax: +86-10-66176450
Received: May 18, 1998
Revised: June 20, 1998
Accepted: July 14, 1998
Published online: August 15, 1998

Abstract

AIM: To investigate the effect of cytokines on the liver necrosis.

METHODS: rIL (interleukin)-1, rIL-6, rIFN (interferon)γ, rTNF (tumor necrosis factor)α with or without D-galactosamine (D-GAL) were injected into the abdominal cavity of mice separately. ALT, TBIL (total bilirubin) and histological changes were observed.

RESULTS: There was no effect on hepatocyte of normal mice after injection of rIL-1, rIL-6, rIFN alone or together. The serum total bilirubin (TBIL) and liver necrosis of mice increased after rTNFα, rIL-6 or rIFNγ were used separately with D-GAL. The TBIL level (μmol/L)was 46.19 ± 10.62, 44.55 ± 12.9 and 41.94 ± 14.9, higher than that caused by D-GAL alone (TBIL, 26.67 μmol/L ± 11.14 μmol/L). The serum TBIL of mice and the degree of liver necrosis increased after injection of IL-1, IL-6 with D-GAL and rTNFα.

CONCLUSION: Cytokines, like IL-1, IL-6, IFNγ and TNFα joined in the process of hepatocyte necrosis. They can enhance the degree of liver necrosis induced by D-GAL.

Key Words: hepatitis, liver necrosis, tumor necrosis factor, interleukins, interferon



INTRODUCTION

Immune system in human body is a net system and so are the effects of cytokines, which can be affected by other cytokines. They promote or inhibit each other, TNFα can aggravate hepatic necrosis[1] , and its effect is also influenced by other cytokines. The levels of IL-1, IL-6 and IFNγ in plasma of hepatitis patients were increased after infection[2-6] . We investigated the effect of multicytokines to understand the synergistic action of multicytokines.

MATERIALS AND METHODS
Material and animal

Animal Ninety-six Balb/c male mice weighing 20 g each were used. They were provided by the Center of Experiment Animal of Chinese Academy of Medical Sciences.

Reagent rIL-1 (105 U/mL), rIL-6 (105 U/mL),rIFN ( 5 × 10 U/mL ) and rTNF α ( 5 × 105 U/mL) were provided by the Chinese Academy of Military Medical Sciences. D-GAL were derived from Department of Chemistry, Chongqing Medical University.

Method

The effect of rIL-1, rIL-6, rTNFαand rIFNγon normal mice Thirty mice were selected and divided into 5 groups. rIL-1 (106 U/kg), rIL-6 (106 U/kg), rIFNγ (5 × 106 U/kg) andrTNFα (5 × 105 U/kg) were injected into the abdominal cavity of mice separately and normal saline was used for the control. TBIL and ALT were detected 48 h after the injection. The pathologic changes of the liver were observed.

The combined effect of TNFαwith IL-1 or IL-6 or IFNγon liver Eighteen mice were selected and divided into 3 groups. TBIL and ALT were detected 48 h after injection ofrTNFα with rIL-1, or rIL-6, or rIFNγ separately into the abdominal cavity. Liver histological changes were observed at the same time.

The aggravating effect of rIL-1, rIL-6, rIFNγand rTNFαseparately in liver necrosis Thirty mice were divided into 5 groups. D-GAL (1.5 g/kg), or D-GAL with rIL-1 (5 × 104 U/kg) or rIL-6 (5 × 104 U/kg) or rIFNγ (2.5 × 105 U/kg) or rTNFα (1 × 104 U/kg) were injected separately into abdominal cavity of mice. Serum TBIL and pathologic changes in liver were compared with the control after 48 h.

The rest 18 mice were divided into 3 groups. D-GAL and rTNFα with rIL-1 or rIL-6 or rIFNγ (the same dose as above) were injected into the abdominal cavity of mice separately.

ALT and TBIL detection Beckman Biochemistry Machine was used to detect the serum ALT and TBIL.

Methods of liver biopsy[7] Hepatic tissues were taken and fixed in Bovin’s fluid. After dehydration they were embedded in paraffin wax, and sections were made, and stained by HE. We marked mild degeneration as - or ±, spot necrosis as +, small piece necrosis as ++, sublarge necrosis as +++, large necrosis as ++++.

Statistical analysisχ2 test was used to compare the difference among groups.

RESULTS
The effect of multicytokines on normal liver of mice

rTNFα, rIL-1, rIL-6 and rIFNγ were injected into the abdominal cavity of normal mice separately. The changes of their hepatic function are shown in Table 1. And the results of their hepatic histologic examination were-or ±. There was no difference from normal control. There was no difference in TBIL and ALT either between each group, indicating that the injection of rTNFα, rIL-1, rIL-6 and rIFNγ have no effects on liver function and liver histology of normal mice.

Table 1 The changes of liver function after cytokines injection in mice (-x±s).
nTBIL(μmol/L)ALT(IU/L)AST(IU/L)
Control67.28 ± 4.8246 ± 4187 ± 28
rTNFα38.70 ± 5.3450 ± 1189 ± 27
rIL-137.23 ± 0.8740 ± 576 ± 10
rIL-6311.77 ± 3.5131 ± 162 ± 2
rIFNγ39.30 ± 2.731 ± 589 ± 13
The effect of rTNFα with rIL-1 or rIL-6 or rIFNγ on normal mice

rTNF α with rIL-1, or rIL-6, or rIFN γ were injected into the abdominal cavity of normal mice. The changes of their liver function are shown in Table 2. There was no difference in TBIL and ALT among the groups, and no difference in liver histology compared with normal control. So, it is obvious that rTNFα with rIL-1 or rIL-6 or rIFNγ had no effect on liver function and liver histology of normal mice.

Table 2 The combined effect of rTNFα with rIL-1 or rIL-6 or rIFNγ on liver function of normal mice (-x±s).
nTBIL(μmol/L)ALT(IU/L)AST(IU/L)
Control67.28 ± 4.8246 ± 4187 ± 28
rTNFα38.70 ± 5.3450 ± 1189 ± 27
rTNFα + rIFNγ37.38 ± 6.0132 ± 3100 ± 14
rTNFα + rIL-138.59 ± 5.942 ± 11128 ± 19
rTNFα + rIL-6310.85 ± 3.2536 ± 5115 ± 12
The effect of cytokines on mice liver

DGal combined with cytokines were injected separately into the abdominal cavity of mice. The results of liver function and hepatic histology are shown in Table 3. The level of TBIL in different groups of cytokine was higher than that of controls. The TBIL level in groups of D + rIL-6,D + rIFN and D + rTNFα rose significantly compared with group D, and hepatic necrosis worsened. There was no difference in TBIL level between group D + rIL-1 and group D.

Table 3 The effect of D-GAL with cytokines on TBIL and histological changes of liver.
GroupnTBIL(μmol/L)Histological changes (n)
±+++
Control67.28 ± 4.826
D-GAL626.67 ± 11.146
D + rIL-1629.69 ± 9.66
D + rIL-6645.55 ± 12.9a15
D + rIFNγ641.94 ± 14.9a24
D + rTNFα646.19 ± 10.62a24

DGal and rTNFα with rIL-1, or rIL-6 or rIFNγ were injected into the abdominal cavity of mice. The results of liver function and hepatic histology are shown in Table 4. The degree of hepatic necrosis was more severe and the level of TBIL was higher in group D + T + 1 and group D + T + 6 than in group D + T. There was no significant difference between group D + T + IFNγ and group D + T. It is suggested that D + T can raise the level of TBIL and the degree of hepatic necrosis. And adding, rIL-1 and rIL-6 can increase the level of TBIL and ALT and enhance the degree of liver necrosis, but no difference with rIFNγ.

Table 4 The effects of DGal and rTNFα with rIL-1, rIL-6, rIFNγ separately on TBIL and hepatic cell of mice.
GroupnBIL(μmol/L) (-x±s)Histological changes
-or ±++++++++++
Control67.28 ± 4.86
D + rTNFα646.19 ± 10.624
D + rTNFα + rIL-1666.27 ± 18.7a33a
D + rTNFα + rIL-6669.28 +18.9a24a
D + rTNFα + rIFNγ636.75 ± 14.524
DISCUSSION

Our experimental results showed that various cytokines, such as TNFα, IL-1, IL-6 and rIFNγ alone or together have no effect on liver. But TNFα, rIL-6 and rIFNγ can enhance the degree of liver lesions caused by D-Gal and rIL-1 and rIL-6 can aggravate liver necrosis caused by TNFα.

Lipopolysaccharide (LPS) is a very strong inducer of many cytokines. It can induce IL-1, IL-6,TNFα and IFNγ and so on[8,9] e.g., hepatitis B can induce TNFα in hepatocytes[10]. Besides increased TNFα in patients with viral hepatitis, the level of many other cytokines was elevated, for example IL-1, IL-6 and IFNγ. The effect of any cytokine could be affected by other cytokines. IFNγ can induce the production of TNFα[11], which produced cytokines including IL-1 and IL-6. So, not only TNFα, but many other cytokines affect the liver function when infections appear. Our results demonstrated the role of multiple cytokines in hepatic necrosis. There might be many routes for multiple cytokines to worsen the hepatic damage in hepatitis. One of the routes is local Shwartzman reaction. TNFα and LPS can induce Shwartzman as either sensitizing agent or stimulating agent [12]. TNFα together with IL-1, IL-6 can aggravate hepatic necrosis and bleeding. They can spoil the cell membrane by inducing indirectly serine protease and by activating phosphatase A2[13]. Cytokines could not induce hepatic lesions in mice with normal liver function. The susceptibility to cytokines was increased after injection of D-GAL. D-GAL, actimycin D and mitomycin C are hepatocyte-specific inhibitors of RNA synthesis. The toxic effect of cytokine can increase dramatically when cytokines injected with DGAL[14]. The catabolism and anabolism of protein in hepatocytes are affected in hepatopathy and the toxic effect of cytokine can reveal in hepatitis.

It can be supposed that viral infection and bacteriotoxemia in patients with hepatitis can induce a large amount of cytokines and aggravate liver necrosis through their interaction, resulting in severe hepatitis. To study the effect of multicytokines in patients with hepatitis is of great importance to understand the mechanism of hepatic necrosis and to search for effective means for prevention and treatment of liver necrosis.

Footnotes

Project supported by National Natural Science Foundation of China, No.39170704.

References
1.  Yu Y, Si C, Lang Z. [The effect of tumor necrosis factor alpha on hepatic necrosis in viral hepatitis]. Zhonghua Neike Zazhi. 1996;35:28-31.  [PubMed]  [DOI]  [Cited in This Article: ]
2.  Anastassakos C, Alexander GJ, Wolstencroft RA, Avery JA, Portmann BC, Panayi GS, Dumonde DC, Eddleston AL, Williams R. Interleukin-1 and interleukin-2 activity in chronic hepatitis B virus infection. Gastroenterology. 1988;94:999-1005.  [PubMed]  [DOI]  [Cited in This Article: ]
3.  Kakumu S, Shinagawa T, Ishikawa T, Yoshioka K, Wakita T, Ito Y, Takayanagi M, Ida N. Serum interleukin 6 levels in patients with chronic hepatitis B. Am J Gastroenterol. 1991;86:1804-1808.  [PubMed]  [DOI]  [Cited in This Article: ]
4.  Khoruts A, Stahnke L, McClain CJ, Logan G, Allen JI. Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology. 1991;13:267-276.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 353]  [Cited by in F6Publishing: 317]  [Article Influence: 9.6]  [Reference Citation Analysis (0)]
5.  McClain C, Hill D, Schmidt J, Diehl AM. Cytokines and alcoholic liver disease. Semin Liver Dis. 1993;13:170-182.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 209]  [Cited by in F6Publishing: 180]  [Article Influence: 5.8]  [Reference Citation Analysis (0)]
6.  Sun Y, Tokushige K, Isono E, Yamauchi K, Obata H. Elevated serum interleukin-6 levels in patients with acute hepatitis. J Clin Immunol. 1992;12:197-200.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 33]  [Cited by in F6Publishing: 36]  [Article Influence: 1.1]  [Reference Citation Analysis (0)]
7.  Huang F, Wang JY, Gao H, Dong XJ. The level of tumor necrosis factor in plasma of mice and the protection effect of HCG and PGE.. J Clin Med Univ. 1993;22:275-277.  [PubMed]  [DOI]  [Cited in This Article: ]
8.  Blanchard DK, Djeu JY, Klein TW, Friedman H, Stewart WE. Interferon-gamma induction by lipopolysaccharide: dependence on interleukin 2 and macrophages. J Immunol. 1986;136:963-970.  [PubMed]  [DOI]  [Cited in This Article: ]
9.  Lehmann V, Freudenberg MA, Galanos C. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice. J Exp Med. 1987;165:657-663.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 417]  [Cited by in F6Publishing: 444]  [Article Influence: 12.0]  [Reference Citation Analysis (0)]
10.  González-Amaro R, García-Monzón C, García-Buey L, Moreno-Otero R, Alonso JL, Yagüe E, Pivel JP, López-Cabrera M, Fernández-Ruiz E, Sánchez-Madrid F. Induction of tumor necrosis factor alpha production by human hepatocytes in chronic viral hepatitis. J Exp Med. 1994;179:841-848.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 205]  [Cited by in F6Publishing: 223]  [Article Influence: 7.4]  [Reference Citation Analysis (0)]
11.  Marshall JS, Dolovich J, and Waserman S. The induction of peripheral blood mononuclear cell TNFα production by IFNγ can be inhibited by budedonide. J Aller Clin Immunol. 1995;95:365.  [PubMed]  [DOI]  [Cited in This Article: ]
12.  Bian ZQ, Wang WY, Qin YZ, Qin RM, Wang GZ, Qin HY. Experimented study of Tumor-Necrosis Factor induced acute liver necrosis in Duckling infected with DHBV.. J Chin Infect Dis. 1992;10:88-92.  [PubMed]  [DOI]  [Cited in This Article: ]
13.  Suffys P, Beyaert R, Van Roy F, Fiers W. Involvement of a serine protease in tumour-necrosis-factor-mediated cytotoxicity. Eur J Biochem. 1988;178:257-265.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 44]  [Cited by in F6Publishing: 49]  [Article Influence: 1.4]  [Reference Citation Analysis (0)]
14.  Alcorn JM, Fierer J, Chojkier M. The acute-phase response protects mice from D-galactosamine sensitization to endotoxin and tumor necrosis factor-alpha. Hepatology. 1992;15:122-129.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 56]  [Cited by in F6Publishing: 57]  [Article Influence: 1.8]  [Reference Citation Analysis (0)]